# SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF

> **NCT05852704** · PHASE3 · RECRUITING · sponsor: **Region Örebro County** · enrollment: 800 (estimated)

## Conditions studied

- Chronic Coronary Syndrome
- Atrial Fibrillation

## Interventions

- **DRUG:** Dapagliflozin 10mg Tab
- **DRUG:** Placebo Tab

## Key facts

- **NCT ID:** NCT05852704
- **Lead sponsor:** Region Örebro County
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-04
- **Primary completion:** 2027-12-04
- **Final completion:** 2028-12-04
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2025-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05852704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05852704, "SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05852704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*